BACKGROUND AND OBJECTIVES
PHH-1V, a protein-based, non-mRNA, bivalent, adjuvanted COVID-19 vaccine, has demonstrated strong immunogenicity and favorable safety as a booster in adults. This study evaluated PHH-1V as a heterologous booster in adolescents.
METHODS
HIPRA-HH-3 was a phase IIb, open-label, multicenter, non...
Ignasi Esteban Riera, R. Pérez-Caballero, Silvina Natalini Martínez et al.· Pediatrics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.